PHAC's National HIV and Retrovirology Laboratories provide a comprehensive range of laboratory science services and expertise, including surveillance research and quality assurance, to laboratories in Canada and abroad.
HIV/AIDS Epi Updates - published annually by the Centre for Infectious Disease Prevention and Control (CIDPC) Surveillance and Risk Assessment Division - summarize recent trends and developments related to the HIV epidemic in Canada. HIV/AIDS Epi Updates are based on non-nominal confidential data provided to CIDPC by provincial/territorial HIV/AIDS coordinators, public health units, laboratories, health care providers and reporting physicians. Topics include national HIV estimates, HIV testing and reporting, population-specific analyses and risk behaviours.
Download or order HIV/AIDS Epi Updates
Semi-annual surveillance reports published by the Surveillance and Risk Assessment Division provide a snapshot of persons who have been diagnosed with HIV and AIDS in Canada. These reports include a summary of main findings, followed by a more detailed breakdown of positive HIV test reports, the HIV status of infants exposed perinatally to HIV infection, reported AIDS diagnoses in Canada, mortality due to HIV/AIDS in Canada, and international statistics on AIDS. With the exception of the international section, the reports are based on non-nominal confidential data provided to the Centre for Infectious Disease Prevention and Control (CIDPC) by provincial/territorial HIV/AIDS coordinators, public health units, laboratories, health care providers and reporting physicians.
Download or order HIV and AIDS in Canada: Surveillance Reports
The Surveillance and Risk Assessment Division also collaborates with the National HIV and Retrovirology Laboratories and participating provincial partners to conduct national HIV strain and drug resistance surveillance.
No comments:
Post a Comment